IBM Slashes Thousands of Jobs Amid AI Boom – Why Big Blue Is Cutting Staff Now

IBM Slashes Thousands of Jobs Amid AI Boom – Why Big Blue Is Cutting Staff Now

IBM’s AI-Era Layoffs and Strategic Shift IBM’s decision to cut thousands of jobs by year-end comes at a paradoxical moment when artificial intelligence is booming across the tech sector. The company announced that a “low single-digit percentage” of its global workforce will be impacted in Q4 2025 Newsweek. In practice, this means on the order of three to eight thousand employees could lose their jobs in the coming weeks. An IBM spokesperson framed the move as a routine workforce adjustment, saying IBM continually reviews its staff mix and will “at times rebalance accordingly” to align with business priorities Gvwire. What’s
Stocks Skyrocket to Record Highs as Fed Set to Cut Rates Again

Fed’s $50 Billion Repo Bailout: Credit Crunch Canary or Just Month-End Jitters?

Fed Pumps Billions to Calm a Cash Crunch Late last week, U.S. money markets showed unusual signs of strain. On Friday, October 31, banks and dealers suddenly found cash in short supply to meet their routine funding needs. Overnight lending rates – the cost for banks to borrow short-term cash – surged above the Federal Reserve’s target range, indicating that banks were scrambling for dollarsreuters.com. In response, the Federal Reserve executed a massive repo operation to flood the system with cash and stabilize rates. In a repo (short for repurchase agreement), a bank can borrow overnight from the Fed by
5 November 2025
Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Novo Nordisk’s Weight-Loss Drug Boom Hits a Wall – Wegovy Slowdown Sparks Stock Slump and Forecast Cut

Once Sky-High Valuation Falters Amid Weight-Loss Drug Headwinds Just a year ago, Novo Nordisk – buoyed by the meteoric success of its weight-loss injection Wegovy – briefly eclipsed all other European companies in market valuereuters.com. The Danish pharmaceutical giant enjoyed surging sales as Wegovy and its type-2 diabetes sibling Ozempic (both containing the GLP-1 agonist semaglutide) became global sensations, with millions seeking their dramatic weight-loss benefits. However, 2025 has seen a sharp reversal of fortune. A “slew of headwinds has shaken investor confidence” in Novo Nordisk’s once-dominant growth storystockanalysis.com. The company’s share price has plummeted nearly 50% year-to-date amid signs
5 November 2025
Investors Beware: 7 Stocks to Avoid on October 22, 2025 Amid Alarming Warnings

Stocks Plunge on AI Bubble Fears as Wall Street Warns of a 20% Correction

Rally Meets Reality: Tech Stocks Finally Cool Off After a year of spectacular gains, stocks have abruptly stumbled, raising the question of whether the market got ahead of itself. The S&P 500 and Nasdaq Composite just suffered their biggest one-day percentage drops since early Octoberchannelnewsasia.com, a sign that the gravity-defying surge in tech shares is meeting some pushback. On Tuesday (Nov. 4), the Nasdaq sank over 2% while the S&P 500 fell around 1.2%, and the Dow – which is less tech-centric – dipped 0.5%channelnewsasia.com. What triggered the abrupt shift in sentiment? Valuations. Investors are increasingly nervous that the price
Zeta Global (ZETA) – 17th Straight Beat & Raise Quarter Ignites AI-Cloud Rally – Analysts Eye ~$28 Target (≈+70% Upside)

Zeta Global (ZETA) – 17th Straight Beat & Raise Quarter Ignites AI-Cloud Rally – Analysts Eye ~$28 Target (≈+70% Upside)

Stock Performance & Valuation Zeta’s stock has trended down from its late-2024 highs (~$36.7) as broader growth-tech valuation pressures emerged. At the Nov 4 close, ZETA was ~$16.70stockanalysis.com, near its 52-week low and well below its peak. Over the year it’s down ~–7%marketbeat.com (since start-2025), while smaller tech peers have also lagged. On Nov 4 its volume was ~11.2 M sharesstockanalysis.com, reflecting heavy trading after earnings. Technically, ZETA carries a higher beta (~1.28stockanalysis.com) so it tends to amplify tech market moves. The stock’s drop on Nov 4 (–5.2% on the closestockanalysis.com) came ahead of the after-market earnings release, amid a weak
Rivian Slashes 600 Jobs as EV Demand Slumps – Stock Hits & Experts Sound Alarm

Rivian Rally or Risk? EV Start-up Stock Jumps on Q3 Beat, Layoffs & R2 Hype

Key Facts: Rivian’s stock (NASDAQ: RIVN) closed around $13 on Nov. 4, 2025 (52-week range ~$9.50–$17.15stockanalysis.com), giving it a market cap of about $15.2 billionstockanalysis.com. In Q3 2025 Rivian delivered 13,201 vehicles (highest quarter of 2025) and reported $1.558 billion in revenue, up 78% year-over-yearbusinesswire.com. Adjusted gross profit turned positive ($24 M) for the quarterbusinesswire.com. Management kept 2025 delivery guidance at 41,500–43,500 vehiclesbusinesswire.com (midpoint cut vs. prior); losing the $7,500 federal EV tax credit caused a short-term pull-forward of orders, then softer demandreuters.comreuters.com. Rivian announced a 600‑job layoff (4.5%) on Oct. 23 to cut costsreuters.com. CEO RJ Scaringe said the company
Is ALAR Stock the Next AI Goldmine? Discover Alarum’s Explosive Run and What Analysts Are Saying

Is ALAR Stock the Next AI Goldmine? Discover Alarum’s Explosive Run and What Analysts Are Saying

Stock Price Performance (as of Nov 4, 2025) Alarum Technologies (NYSE: ALAR) has rallied strongly in 2025. After closing around $16.25 on Nov 3stockinvest.us, the stock is off its all-time high (~$18.00) but still stands well above its 2024 lows (~$5.45marketbeat.com). In the last two weeks alone it has gained ~10.8%stockinvest.us. Year-to-date shares are up about +55%investing.com, driven by excitement over AI-related business. Volume has picked up on rising days, indicating positive investor intereststockinvest.us. Notably, the 50-day moving average is rising and has crossed above the 200-day average, a classic bullish signalstockinvest.us. Recent trading has been a bit choppy. For
UPST Stock Rockets on AI Lending Growth – What’s Next?

UPST Stock Rockets on AI Lending Growth – What’s Next?

Q3 2025 Results and Guidance Upstart’s Q3 earnings beat expectations, driven by its AI lending platform expansion. Transaction originations reached $2.9B (up 80% YoY) and 428K loans were originated (a +128% jump)businesswire.com. Revenue hit $277M (+71% YoY)businesswire.com, with fee income ~$259M (+54%). Crucially, Upstart swung to profitability: GAAP operating income was $23.7M (vs a $45.2M loss prior year), and GAAP net income $31.8M (vs -$6.8M)businesswire.com. Adjusted EBITDA was $71.2M (26% margin) vs just $1.4M a year earlierbusinesswire.com. Management’s outlook remains positive: they expect Q4 revenue ~$288M and FY2025 revenue ~$1.035Bbusinesswire.combusinesswire.com. Guidance anticipates continued healthy margins (53% contribution margin Q4, ~22%
4 November 2025
Pinterest Stock Takes on Gen Z: Is PINS the Next AI-Powered Shopping Juggernaut?

Pinterest (PINS) Q3 Shock: 600M Users & 17% Growth, New AI Tools – Stock Tanks

Stock Price & Recent Trading PINS stock has been choppy heading into earnings. On Nov. 3 it closed at $33.70, up about +1.8% on the daybenzinga.com. On Nov. 4 (Q3 report day), shares fell: the stock opened near $32.68 and closed at $32.91stockanalysis.com (–2.34% intraday) amid cautious sentiment. Trading volume on Nov. 4 was roughly 16.9 million sharesstockanalysis.com, above its recent average. After the earnings release, PINS plunged further: in after-hours trading on Nov. 4 it traded around $27.6–$27.9stockanalysis.combenzinga.com (about –15% from the close). This volatility reflects investor reaction to the missed EPS and soft guidance. In context, Pinterest’s stock
Axon Stock Rockets 420% Overseas as Wall Street Targets $1,000 – Should You Buy the Dip?

Axon Enterprise Rockets Past Revenue Goals – But EPS Miss Sends Stock Reeling

Q3 2025 Earnings Report Axon’s Q3 results (announced Oct. 31) beat revenue expectations but showed a small profit shortfall. The company “delivered another record quarter, with revenue growing 31% year over year to $711 million”prnewswire.com, marking its seventh straight quarter above 30% growth. Sales growth was driven by the software business – Axon’s Software & Services segment grew 41% to $305Mprnewswire.com – as well as by strong demand for Tasers and body cameras. On the profitability side, Axon reported a tiny GAAP net loss of just $2.0M (–$0.03 per share)prnewswire.com, largely due to investment in staff and R&D. By contrast,
4 November 2025
Astera Labs Stock Skyrockets on AI Buzz and Photonics Deal – Can ALAB Keep Climbing?

Astera Labs (ALAB) Stock Surges on AI Boom – What Wall Street Says

Stock Price and Recent Performance Astera Labs has been volatile lately. After peaking above $225 in early October 2025, shares plunged on Oct.14–15 amid news of AMD’s big Oracle GPU deal (raising concerns about competition)finviz.com. For example, on Oct 15 ALAB fell 19.0% to close $161.55finviz.com after the AMD/Oracle announcement, which analysts feared could dampen demand for Astera’s productsfinviz.com. The stock bounced back slightly afterward, trading around $170–$190 in late Oct. By Nov 3 it closed at $191.56 (up ~2.6% that day)stockanalysis.com, then pulled back to $179.31 on Nov 4stockanalysis.com (–6.4%). The 2025 YTD chart shows massive moves: ALAB ran
4 November 2025
CAVA Group Stock: 20% Growth vs 60% Plunge – What’s Really Happening?

CAVA Group Stock: 20% Growth vs 60% Plunge – What’s Really Happening?

Stock Price & Recent Performance Cava’s stock has fallen sharply in 2025. After peaking near $172 in late 2024, it traded around $51.7 at the Nov. 4, 2025 closestockanalysis.com. That marks a roughly 60% drop from its high and a ~52% decline year-to-datestockanalysis.comstocktwits.com. In late October, the stock plunged (~11% on Oct 30 alone) when rival Chipotle trimmed its outlookbusinessinsider.com, and it fell another ~2–3% at the start of November. In fact, one trading report notes a 15.5% slide “last week” (week ending Nov. 1) – the steepest since Auguststocktwits.com. Overall, CAVA has significantly underperformed the broader market and even
4 November 2025

Stock Market Today

Stellantis stock slides 24% after €22 billion EV reset kills 2026 dividend — what to watch next

Stellantis stock slides 24% after €22 billion EV reset kills 2026 dividend — what to watch next

7 February 2026
Stellantis shares plunged 23.7% to $7.28 Friday after the company disclosed about €22.2 billion in charges tied to a reset of its electric-vehicle strategy and said it will skip its 2026 dividend. The automaker flagged a preliminary net loss of €19–21 billion for the second half of 2025. Shares rose 1.6% in late after-hours trading. Investors await Feb. 26 results and a May 21 Investor Day.
Intel stock jumps on China server CPU delays as traders map the week ahead

Intel stock jumps on China server CPU delays as traders map the week ahead

7 February 2026
Intel shares rose 4.87% to $50.59 Friday, trailing gains by Nvidia and Broadcom as chip stocks rallied. Sources said Intel and AMD warned Chinese customers of longer waits and higher prices for some server CPUs, with Intel lead times reaching six months. Intel said China accounts for over 20% of its revenue. Investors await key U.S. jobs and inflation data next week.
IRS tax refund delays? Watchdog flags staffing crunch as 2026 filing season ramps up

IRS tax refund delays? Watchdog flags staffing crunch as 2026 filing season ramps up

7 February 2026
IRS staffing has dropped to 2021 levels as the 2026 tax filing season begins, according to a Treasury watchdog. The agency faces a backlog of about 2 million returns, 129% above pre-pandemic levels. Most e-filers using direct deposit still get refunds within 21 days, but paper filings and amended returns could see delays. The IRS lowered its call-answer target to 70% for this season.
Plug Power stock jumps 12% after vote setback, with Feb 17 share decision in focus

Plug Power stock jumps 12% after vote setback, with Feb 17 share decision in focus

7 February 2026
Plug Power shares rose 11.6% Friday to $2.08 after a sharp drop the previous day, as attention shifted to a Feb. 17 shareholder vote on expanding authorized shares. The company failed to secure enough votes earlier this week and is urging overseas holders to participate. CEO Andy Marsh cited difficulties for European investors in casting ballots. A reverse stock split remains possible if the proposal fails.
Go toTop